AFR
"Long-term backers
Despite Mesoblast’s failure to date to get its drug approved in the US, it has attracted a clutch of long-term backers, including Alex Waislitz’s Thorney Capital (Waislitz shared an apartment in New York years ago with Itescu), M&G Investors, and former Independent Asset Management founder Greg Matthews.
Its retail supporters had remained optimistic in the lead-up to the FDA decision. Threads on HotCopper, an online stock chat platform, set up this week include “How will you celebrate when the FDA gives the Tick” and “2023: The Final Countdown”.
By Thursday afternoon, when no FDA update had been provided, the mood was becoming slightly less upbeat. “If the announcement does not have ‘Approved’ in the title, The End,” wrote one poster, though with far fewer comments and views than the others."
LINK
Mesoblast stock(rock)-take March 2024, page-254
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.085(7.69%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.20 | $1.09 | $13.21M | 11.37M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 75212 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |